-
Mashup Score: 0
The Prescription Drug User Fee Act target action date is set for quarter 3 of this year.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 2Variability in treatment of node-positive prostate cancer after RP suggests QI opportunities - 4 hour(s) ago
“The wide variability that we found across MUSIC practices suggests an opportunity for us for quality improvement initiatives and additional evidence surrounding who should receive secondary treatment and what modalities,” says Daniel A. Triner, MD, PhD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 1Irrigation systems evaluated for intrarenal pressure, flow rate - 7 hour(s) ago
“We found that the SAPS is associated with higher intrarenal pressure and flow rate when compared to automated pumps,” said Lucas B. Vergamini, MD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 0Expert discusses novel approach to ctDNA detection in MIBC - 1 day(s) ago
“[This] shows a different approach for detecting circulating tumor DNA in bladder cancer patients, and it opens up the possibility for other biorepositories that have serum samples to also enter the ctDNA research environment,” says Richard T. Bryan, MBChB, PhD, MRCS, FacadTM.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 3Dr. Meeks highlights the recent innovation in bladder cancer - 1 day(s) ago
“BCG worked well enough that we could give it to patients and it worked pretty well. But having the shortage, I think, has ultimately led to a bottleneck and then an explosion in the technology and the resources and the techniques to treat patients with non–muscle-invasive bladder cancer,” says Joshua J. Meeks, MD, PhD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 2
Experts on kidney cancer review challenges associated with limitations of conventional imaging for assessing renal masses and how to potentially improve sensitivity and specificity.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 3Combination nivolumab/nab-paclitaxel shows efficacy in MIBC - 2 day(s) ago
“[The] NURE-Combo trial provided insights into the potential value of expanding chemotherapy combinations with immune checkpoint [inhibitors] in muscle-invasive disease,” said Chiara Mercinelli, MD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 2
Combination treatment with burst wave lithotripsy and ultrasonic propulsion for small, asymptomatic renal stones is feasible.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 11
“We found that approximately 2 out of every 3 patients with node-positive disease go on to some form of secondary treatment within 12 months,” says Daniel A. Triner, MD, PhD.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
-
Mashup Score: 1Dosing begins in study of PSMA-targeted therapy in mCRPC - 3 day(s) ago
The phase 2/3 AlphaBreak trial is evaluating the safety and efficacy of FPI-2265 in patients with mCRPC who have been previously treated with 177Lu-PSMA radiotherapy.
Source: www.urologytimes.comCategories: General Medicine News, UrologyTweet
The @US_FDA has accepted a supplemental new drug application for vibegron for the treatment of men with OAB symptoms who are receiving pharmacological treatments for BPH. #FDA #urology https://t.co/YoE1SXXvj9